Scope of the Report Key Target Audience Investors and Venture Capitalist Firms Government and Regulatory Bodies (e.g., Ministry of Health and Welfare, Korea Food and Drug Administration) Pharmaceutical Manufacturers Healthcare Providers and Hospitals Insurance Companies Pharmacy Chains and Retail Pharmacies Biotechnology Firms Health Technology Assessment Agencies Players Mentioned in the Report: Novo Nordisk A/S Eli Lilly and Company Sanofi S.A
Cellulases: From bioactivity to a variety of industrial applications
Before the lag time, 12% of the thyroid cancer group and 9.6% of the control group used GLP-1 receptor agonists, with more than 80% in both groups using liraglutide (Victoza, Novo Nordisk)
Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, et al
How Much Vitamin C on Carnivore Diet Should I Aim For Daily